A draft of another seminar I've prepared on a key topic - the video will follow, like/follow this and I'll make sure you get to have a look! (note: the slides without the narrative are in fairness limited in value, but might pique the interest)
1. The Cholesterol Conundrum
What does the Latest Science Say?
Ivor Cummins BE (Chem)
March 21st 2014
2013 Ivor Cummins BE(Chem) MIEI
2. Why are we in this room today
- How does this come about?
Academic /
Educational History
Problem Solving
Experience / Aptitude
2013 Ivor Cummins BE(Chem) MIEI
3. Quick Update from my last Seminar
At last, The unbiased experts
are stepping up to the plate:
• Six teaspoons max in 24 hours?
• That’s less than a single can of
your favorite sugary beverage, and
assumes NO other sugar for the
rest of the day?
• Looks like the Emperor’s suit is
getting frayed…..
• Gloves off lads, better pour some
money into the lobbying chest, and
shut this thing down quick
2013 Ivor Cummins BE(Chem) MIEI
4. 2013 Ivor Cummins BE(Chem) MIEI
1. The Key Molecules
2. The Key Particles
3. Our Common Enemy
4. The Risk Factors
5. How the Cholesterol Processing
System Works – High Level
6. The $1M Question – What Drives up
the Risk Factors?
The Conundrum Content:
6. Cholesterol and Triglyceride
• Cholesterol is a Sterol Molecule that is used to build
cells, hormones and other core physiological elements
• Is critical, and fundamental for life to exist
• Is a key element of your bodies damage repair system
• Is a precursor to the synthesis of Vitamin D, which in
turn is one of the most important agents for mortality
deferral – we’ll look at this later….
• Finally, cholesterol generally gets blamed for disease
pretty much as a paramedic on the scene might be
blamed for the car crash
Cholesterol – for Life Itself
• Triglyceride (aka Triacylglycerol) is a form of fat
• Is three Fatty Acids on a glycerol (sugar-like) backbone
• Enters the body via fat-containing food
• Is also synthesized by the body (neolipogenisis) for
various reasons
• Can be good or bad: depends on source, location and
quantity….
Trigylceride – for Energy
2013 Ivor Cummins BE(Chem) MIEI
8. The Lipoprotein Particles – Boats for Cargo
Trigylceride/
Cholesterol
An Apo-
Lipoprotein
Phospholipids The LIPOPROTEIN PARTICLES are transport vessels
(“boats”) created in the body to deliver
Triglyceride and Cholesterol (“cargo”), for energy
transfer, critical synthesis, and healing purposes….
HDL is the so-called “GOOD Cholesterol”
LDL (from VLDL) is the so-called “BAD Cholesterol”
The Chylomicron is the big one, created to ferry
dietary fat and cholesterol, for energy and healing
Chylomicron
100 to 1000nm
sdLDL
<25nm
VLDL is made in the liver to ferry Trigs and Chol…
Small Dense LDL is the real “BAD Cholesterol”
HDL
5-15nm
LDL
>26nm
VLDL
30 to 80nm
2013 Ivor Cummins BE(Chem) MIEI
11. Atherosclerosis and CVD Mechanism
Ingress of Lipoprotein Particles through Endothelium (inner wall)
Uptake of these by immune system Macrophage
Subsequent transformation into “Foam Cells” and buildup of Plaque
Ultimately a decline in vascular health, then breakouts, blockages…..
The Disease Sequence:
+ Ch
Ch Ch
Macrophage
=
FOAM CELL
The Million Dollar Question: What mediates this inflammatory process?
TgCh
ChCh
B100
2013 Ivor Cummins BE(Chem) MIEI
13. Key Predictors of Mortality
– Dysfunctional Lipoprotein Status
• LDL/HDL Ratio
• Serum Triglyceride Levels
• Small Dense LDL and associated LDL Particle COUNT
– Insulin Levels and Insulin Resistance Status
– Blood Glucose Level and HbA1C
– High Blood Pressure (generally driven by the
above scenarios)
– Other markers of Systemic Inflammation
2013 Ivor Cummins BE(Chem) MIEI
14. Total Cholesterol as a predictive factor?
Is the use of cholesterol in mortality risk algorithms in clinical guidelines valid? Ten years prospective data from the
Norwegian HUNT 2 study (>58,000 Participants)
Halfdan Petursson MD,1 Johann A. Sigurdsson MD Dr med,2 Calle Bengtsson MD Dr med,3
Tom I. L. Nilsen Dr Philos4 and Linn Getz MD PhD5
Cardiovascular
Death
IncreasedRisk
IncreasedRisk
Ischemic Heart
Disease Death
2013 Ivor Cummins BE(Chem) MIEI
15. Total Cholesterol as a predictive factor?
Is the use of cholesterol in mortality risk algorithms in clinical guidelines valid? Ten years prospective data from the
Norwegian HUNT 2 study (>58,000 Participants)
Halfdan Petursson MD,1 Johann A. Sigurdsson MD Dr med,2 Calle Bengtsson MD Dr med,3
Tom I. L. Nilsen Dr Philos4 and Linn Getz MD PhD5
Age Confounding is a serious issue
US Versus Other Geographies is an issue
Diagnosing via Total Cholesterol no
longer supported by the science
ALL CAUSE
DEATH….
IncreasedRisk
Key Takeaways:
Total Cholesterol effectively not
considered any more by leading edge
researchers
Economics / Hubris retain bad science
2013 Ivor Cummins BE(Chem) MIEI
16. LDL-C & HDL-C as predictive factors?
Diagram adapted from article in Journal of Cardiovascular Medicine 2011, Vol 00, No 00
2.58 4.13 5.68
HDL=0.65
HDL = 1.16
HDL = 1.68
HDL = 2.20
RiskofHeartDiseaseafter4Years
LDL (the “Bad Cholesterol”)
HDL being adequate/higher is VERY important
The benefit of LDL being low………depends on the HDL status
Risk is determined primarily by the RATIO of these parameters
Diagnosing via LDL is minimally useful in the face of the current science
Heart Disease Risk Vs LDL & HDL
Data from the Framingham Heart Study showing incidence of CAD over 4 years in men 50-70 years old
2013 Ivor Cummins BE(Chem) MIEI
17. LDL-C & HDL-C as predictive factors?
Diagram adapted from article in Journal of Cardiovascular Medicine 2011, Vol 00, No 00
2.58 4.13 5.68
HDL=0.65
HDL = 1.16
HDL = 1.68
HDL = 2.20
RiskofHeartDiseaseafter4Years
LDL (the “Bad Cholesterol”)
HDL being adequate/higher is VERY important
The benefit of LDL being low………depends on the HDL status
Risk is determined primarily by the RATIO of these parameters
Diagnosing via LDL is minimally useful in the face of the current science
Heart Disease Risk Vs LDL & HDL
Data from the Framingham Heart Study showing incidence of CAD over 4 years in men 50-70 years old
XXX
2013 Ivor Cummins BE(Chem) MIEI
Guess Who?
18. SERUM TRIGLYCERIDE as a Predictive Factor
Assmann G, Schulte H. Am J Cardiol. 1992;70:733–737.
Data from the PROCAM Munster Study
Blood Triglyceride Levels are an important Risk Factor for Coronary Disease
However, they should not be judged alone – vital to balance with other factors
Again we see the importance of LDL/HDL Ratios and interactions with Trigs
Key Takeaways:
2013 Ivor Cummins BE(Chem) MIEI
19. SERUM INSULIN as a Predictive Factor
Assmann G, Schulte H. Am J Cardiol. 1992;70:733–737.
Data from the PROCAM Munster Study (from "Interesting slideset around…):
Insulin is fundamental to Coronary Disease and Mortality Risk
Insulin has been grossly underemphasized as a risk factor for decades
Triglyceride risk outgunned by Insulin Status here
Key Takeaways:
2013 Ivor Cummins BE(Chem) MIEI
Data from the Quebec Study Cardiovascular Study:
Despres JP, et al. N Engl J Med. 1996;334:952-957.
20. Data taken from Table 2: Association of Hemoglobin A1c with Cardiovascular Disease and Mortality in
Adults: The European Prospective Investigation into Cancer in Norfolk
Kay-Tee Khaw, MBBChir, FRCP; Nicholas Wareham, MBBS, FRCP; Sheila Bingham, PhD; Robert Luben, BSc; Ailsa Welch, BSc;
and Nicholas Day, PhD
Glucose Levels Anyone? - HbA1c as a Risk Factor
Assmann G, Schulte H. Am J Cardiol. 1992;70:733–737.
HbA1c is the alteration of Red Blood Cells driven by blood glucose levels
This again is closely related to Insulin & Insulin Resistance Status
HbA1c from this particular study is also an independent risk factor
Key Takeaways:
2013 Ivor Cummins BE(Chem) MIEI
21. SERUM INSULIN and LDL Particle Count
Data from the Quebec Study Cardiovascular Study:
Assmann G, Schulte H. Am J Cardiol. 1992;70:733–737.
Again Insulin is key, but significant interaction with LDL Particle Count (ApoB)
LDL Particle Count tracks with Small Dense LDL – I’ll explain this shortly!
Interaction is the operative word – synergy closely follows
Key Takeaways:
2013 Ivor Cummins BE(Chem) MIEI
Lamarche B, et al. Circulation. 1997;95:69-75.
22. Small Dense LDL as a Predictive Factor
Assmann G, Schulte H. Am J Cardiol. 1992;70:733–737.
Small Dense LDL and associated LDL Particle Count are Key
These, along with Insulin / Insulin Resistance Status, are Master Markers
So Let’s look at how it all works, shall we?
Key Takeaways:
2013 Ivor Cummins BE(Chem) MIEI
Reprinted from St-Pierre AC, et al. Circulation. 2001;104:
2295–2299, with permission from Wolters Kluwer Health.
23. 2013 Ivor Cummins BE(Chem) MIEI
4. How the Cholesterol
Processing System
Works - High Level
(Hope appreciate the artwork here,
it took me a while!)
24. The Lipoprotein Particles – Boats for Cargo
Trigylceride/
Cholesterol
An Apo-
Lipoprotein
Phospholipids The LIPOPROTEIN PARTICLES are transport vessels
(“boats”) created in the body to deliver
Triglyceride and Cholesterol (“cargo”), for energy
transfer, critical synthesis, and healing purposes….
HDL is the so-called “GOOD Cholesterol”
LDL (from VLDL) is the so-called “BAD Cholesterol”
The Chylomicron is the big one, created to ferry
dietary fat and cholesterol, for energy and healing
Chylomicron
100 to 1000nm
sdLDL
<25nm
VLDL is made in the liver to ferry Trigs and Chol…
Small Dense LDL is the real “BAD Cholesterol”
HDL
5-15nm
LDL
>26nm
VLDL
30 to 80nm
2013 Ivor Cummins BE(Chem) MIEI
32. Chylomicron Summary
Dietary Fat and Cholesterol is packaged into the
Large Chylomicrons (100-1000nm)
The latter deliver Triglyceride Molecules For
Energy Use in the Heart / Skeletal Muscles
Following this energy transfer, the Chylomicron
remnants have a short half-life of ~20min in the
bloodstream, and are readily taken up by the liver,
thus completing the cycle
However, the latter description assumes moderate
carbohydrate ingestion and insulin secretion….high
carb will spike insulin, suppress Triglyceride utilization,
and increase remnant residence time….
2013 Ivor Cummins BE(Chem) MIEI
33. VLDL, IDL,LDL…..and Small Dense LDL
LDLR
VLDL
Tg
Tg
Tg
Tg
Tg
Tg
Tg
Tg
Ch
Ch
Ch
Ch
E
C II
B100
SR-B1
Ch
Ch
Ch
2013 Ivor Cummins BE(Chem) MIEI
34. VLDL, IDL,LDL…..and Small Dense LDL
C II
LDLR
C II
LPL
VLDL
Tg
Tg
Tg
Tg
Tg
Tg
Tg
Tg
Ch
Ch
Ch
Ch
E
C II
B100
SR-B1
Ch
Ch
Ch
2013 Ivor Cummins BE(Chem) MIEI
35. VLDL, IDL,LDL…..and Small Dense LDL
C II
LDLR
C II
LPL
VLDL
Tg
Tg
Tg
Tg
Tg
Tg
Tg
Tg
Ch
Ch
Ch
Ch
E
C II
B100
IDL
TgTg
Tg
Ch
Ch
Ch
Ch
E
B100
SR-B1
Ch
Ch
Ch
2013 Ivor Cummins BE(Chem) MIEI
36. VLDL, IDL,LDL…..and Small Dense LDL
C II
LDLR
C II
LPL
VLDL
Tg
Tg
Tg
Tg
Tg
Tg
Tg
Tg
Ch
Ch
Ch
Ch
E
C II
B100
IDL
TgTg
Tg
Ch
Ch
Ch
Ch
E
B100
SR-B1
HL
Ch
Ch
Ch
HSL
XXX
Tg
Tg
2013 Ivor Cummins BE(Chem) MIEI
37. VLDL, IDL,LDL…..and Small Dense LDL
C II
LDLR
C II
LPL
VLDL
Tg
Tg
Tg
Tg
Tg
Tg
Tg
Tg
Ch
Ch
Ch
Ch
E
C II
B100
IDL
TgTg
Tg
Ch
Ch
Ch
Ch
E
B100
TgCh
ChCh
B100
LDL
SR-B1
HL
Ch
Ch
Ch
HSL
XXX
Tg
Tg
2013 Ivor Cummins BE(Chem) MIEI
38. VLDL, IDL,LDL…..and Small Dense LDL
C II
LDLR
C II
LPL
VLDL
Tg
Tg
Tg
Tg
Tg
Tg
Tg
Tg
Ch
Ch
Ch
Ch
E
C II
B100
IDL
TgTg
Tg
Ch
Ch
Ch
Ch
E
B100
TgCh
ChCh
B100
LDL
SR-B1
HL
Ch
Ch
Ch
HSL
XXX
Ch
Tg
Tg
Ch
To tissues and cells
2013 Ivor Cummins BE(Chem) MIEI
39. VLDL, IDL,LDL…..and Small Dense LDL
C II
LDLR
C II
LPL
VLDL
Tg
Tg
Tg
Tg
Tg
Tg
Tg
Tg
Ch
Ch
Ch
Ch
E
C II
B100
IDL
TgTg
Tg
Ch
Ch
Ch
Ch
E
B100
TgCh
ChCh
B100
LDL
SR-B1
HL
Ch
Ch
Ch
HSL
XXX
Ch
To tissues and cells
Tg
Tg
Ch
2013 Ivor Cummins BE(Chem) MIEI
40. VLDL, IDL,LDL…..and Small Dense LDL
C II
LDLR
C II
LPL
VLDL
Tg
Tg
Tg
Tg
Tg
Tg
Tg
Tg
Ch
Ch
Ch
Ch
E
C II
B100
IDL
TgTg
Tg
Ch
Ch
Ch
Ch
E
B100
TgCh
ChCh
B100
LDL
SR-B1
TgCh
ChCh
B100
LDL
SD
HL
HL
Ch
Ch
Ch
HSL
XXX
Ch
Tg
Tg
Tg
Ch
TgCh
ChCh
B100
LDL
OX
To tissues and cells
2013 Ivor Cummins BE(Chem) MIEI
41. VLDL, IDL,LDL…..and Small Dense LDL
C II
LDLR
C II
LPL
VLDL
Tg
Tg
Tg
Tg
Tg
Tg
Tg
Tg
Ch
Ch
Ch
Ch
E
C II
B100
IDL
TgTg
Tg
Ch
Ch
Ch
Ch
E
B100
TgCh
ChCh
B100
LDL
SR-B1
TgCh
ChCh
B100
LDL
SD
HL
HL
Ch
Ch
Ch
HSL
XXX
Ch
Tg
Tg
Tg
Ch
TgCh
ChCh
B100
LDL
OX
To tissues and cells
2013 Ivor Cummins BE(Chem) MIEI
42. VLDL, IDL,LDL…..and Small Dense LDL
C II
LDLR
C II
LPL
VLDL
Tg
Tg
Tg
Tg
Tg
Tg
Tg
Tg
Ch
Ch
Ch
Ch
E
C II
B100
IDL
TgTg
Tg
Ch
Ch
Ch
Ch
E
B100
TgCh
ChCh
B100
LDL
SR-B1
TgCh
ChCh
B100
LDL
SD
HL
HL
Ch
Ch
Ch
Ch
Ch Ch
IMMUNE SYSTEM
MACROPHAGE / FOAM CELL
HSL
XXX
Ch
Tg
Tg
Tg
Ch
TgCh
ChCh
B100
LDL
OX
To tissues and cells
2013 Ivor Cummins BE(Chem) MIEI
43. VLDL to LDL Summary
VLDL is produced by the liver to transport Triglyceride
cargo for energy uses, and Cholesterol for building tasks
As Triglyceride is depleted, Apo CII is shed and the
VLDL becomes an IDL; further depletion and shedding
of Apo E results in an LDL particle with Apo B100 only
LDL should deliver cholesterol and ideally be taken up
by the liver receptors before it becomes sdLDL or is
oxidized (bad boats, increasing numbers, more risk!)
Oxidised LDL reduces takeup by liver – and enhances
takeup by macrophage – inflammation and the disease
process is augmented
2013 Ivor Cummins BE(Chem) MIEI
45. HDL…..and Reverse Cholesterol Transport
LDLR
SR-B1
Ch
Ch
Ch
Ch
A
HDL
Tg
E
Ch Adrenal Cortex and
Gonads
2013 Ivor Cummins BE(Chem) MIEI
46. HDL…..and Reverse Cholesterol Transport
LDLR
SR-B1
Ch
Ch
Ch
Ch
A
HDL
Tg
E
Ch Adrenal Cortex and
Gonads
Ch
From tissues and cells
ABC A1
ABC G1
LCAT
2013 Ivor Cummins BE(Chem) MIEI
47. HDL…..and Reverse Cholesterol Transport
LDLR
SR-B1
Ch
Ch
Ch
Ch
A
HDL
Tg
E
Ch Adrenal Cortex and
Gonads
Ch
ABC A1
ABC G1
LCAT
Ch
Ch Ch
IMMUNE SYSTEM
MACROPHAGE / FOAM CELL
ABC A1
ABC G1
From tissues and cells
2013 Ivor Cummins BE(Chem) MIEI
48. HDL…..and Reverse Cholesterol Transport
LDLR
SR-B1
Ch
Ch
Ch
Ch
A
HDL
Tg
E
Ch Adrenal Cortex and
Gonads
Ch
ABC A1
ABC G1
LCAT
Ch
Ch Ch
IMMUNE SYSTEM
MACROPHAGE / FOAM CELL
ABC A1
ABC G1
From tissues and cells
2013 Ivor Cummins BE(Chem) MIEI
49. HDL…..and Reverse Cholesterol Transport
LDLR
SR-B1
Ch
Ch
Ch
Ch
Ch Ch
IMMUNE SYSTEM
MACROPHAGE / FOAM CELL
Ch
A
HDL
Tg
E
Ch
ABC A1
ABC G1
LCAT
LCAT
ABC A1
ABC G1
Ch Adrenal Cortex and
Gonads
From tissues and cells
2013 Ivor Cummins BE(Chem) MIEI
+ Antioxidant
Agents….!
50. HDL…..and Reverse Cholesterol Transport
LDLR
VLDL
Tg
Tg
Tg
Tg
Tg
Tg
Tg
Tg
Ch
Ch
Ch
Ch
E
C II
B100
TgCh
ChCh
B100
LDL
SR-B1
Ch
Ch
Ch
Ch
Ch Ch
IMMUNE SYSTEM
MACROPHAGE / FOAM CELL
Ch
A
HDL
Tg
E
Ch
ABC A1
ABC G1
LCAT
LCAT
Ch
Ch
Tg
Tg
ABC A1
ABC G1
Ch Adrenal Cortex and
Gonads
From tissues and cells
2013 Ivor Cummins BE(Chem) MIEI
+ Antioxidant
Agents….!
51. HDL Summary
HDL has many functions, one of which is to
remove Cholesterol excess from problematic areas
Low / dysfunctional HDL relative ratios generally track
with high blood triglyceride, higher sdLDL and higher
inflammatory status
Thus the various risk factors are connected and
synergistic – and have common drivers
We’ll see how to influence HDL health shortly – and it’s
not as hard as you might think!
2013 Ivor Cummins BE(Chem) MIEI
HDL’s other key role is in moderating oxidation in
general, and of LDL specifically
52. 2013 Ivor Cummins BE(Chem) MIEI
6. The $1M Question –
What Primarily
Drives up the Risk
Factors???
53. Improving the Total Chol / HDL RatioTotCholesterol/HDL
2013 Ivor Cummins BE(Chem) MIEI
Tot Chol / HDL is a good
metric
Increasingly Lower Carb
delivers dose-response
increased improvement
Low Carb exceeds benefits of
low fat regime – even with
NO dieting
Even during the starvation
period, Low Fat regime
struggles
Separate effects of reduced carbohydrate intake and weight loss on
atherogenic dyslipidemia1–3
Ronald M Krauss, Patricia J Blanche, Robin S Rawlings, Harriett S Fernstrom, and Paul T Williams
Data adapted from from Jeff Volek Summary of:
54. Improving the LDL / HDL Particle Ratio
Separate effects of reduced carbohydrate intake and weight loss on
atherogenic dyslipidemia1–3
Ronald M Krauss, Patricia J Blanche, Robin S Rawlings, Harriett S Fernstrom, and Paul T Williams
Data adapted from from Jeff Volek Summary of:
ApoB/ApoA
LDL / HDL key (here we have
even better metric – the
particle COUNT ratio)
Increasingly Lower Carb
delivers dose-response
increased improvement
2013 Ivor Cummins BE(Chem) MIEI
Low Carb far exceeds
benefits of low fat regime –
even with NO dieting
Even during the starvation
period, Low Fat regime fails
55. Improving the Serum Triglyceride Level
TrigReduction
2013 Ivor Cummins BE(Chem) MIEI
Serum Triglyceride –
important to keep this down
Increasingly Lower Carb
delivers dose-response
increased improvement
Even during the starvation
period, Low Fat regime fails
Separate effects of reduced carbohydrate intake and weight loss on
atherogenic dyslipidemia1–3
Ronald M Krauss, Patricia J Blanche, Robin S Rawlings, Harriett S Fernstrom, and Paul T Williams
Data adapted from from Jeff Volek Summary of:
Low Carb far exceeds
benefits of low fat regime –
even with NO dieting
56. Improving LDL Particle DiameterLDLParticleDiameter
2013 Ivor Cummins BE(Chem) MIEI
LDL Particle Diameter is a
serious metric
Increasingly Lower Carb
delivers dose-response
increased improvement
Low Carb far exceeds
benefits of low fat regime,
especially if you don’t diet
Even during the starvation
period, Low Fat regime
struggles
Separate effects of reduced carbohydrate intake and weight loss on
atherogenic dyslipidemia1–3
Ronald M Krauss, Patricia J Blanche, Robin S Rawlings, Harriett S Fernstrom, and Paul T Williams
Data adapted from from Jeff Volek Summary of:
57. Improving HDL LevelsHDL“good”Chol
2013 Ivor Cummins BE(Chem) MIEI
HDL – the higher the better
Increasingly Lower Carb
delivers dose-response
increased improvement
Low Carb far exceeds
benefits of low fat regime,
again even with no dieting
Even during the starvation
period, Low Fat regime fails
Separate effects of reduced carbohydrate intake and weight loss on
atherogenic dyslipidemia1–3
Ronald M Krauss, Patricia J Blanche, Robin S Rawlings, Harriett S Fernstrom, and Paul T Williams
Data adapted from from Jeff Volek Summary of:
58. Another Recent Trial
xxxxx.
ALL markers better with Low Carb regime – including all Inflammation
Only Low Carb enhances HDL, improves small LDL, and ApoB/ApoA ratio
Scientifically this appears to be a fundamental rule, but rigorously challenged?
2013 Ivor Cummins BE(Chem) MIEI
59. 2013 Ivor Cummins BE(Chem) MIEI
For ref....
Another of Many….
ALL markers better with Low Carb regime – including all Inflammation
Only Low Carb enhances HDL, though low GI has a go (!)
Scientifically this appears to be a fundamental rule, but rigorously challenged?
61. Driving Risk Factors: Where are you?
Disease Risk
Marker
High Carb
Low Fat
Low Carb /
High Fat*
Is Lean / Fit
Kcal Control / active
Carb Tolerant
(~30% of people?)
Is Not Lean / Is Not Fit
High Kcal / Sedentary
Carb Intolerant
(~70% of people?)
Enables:
Lean / Fit
Kcal Control / Active
Health and Wellbeing
Visceral Fat: Waist+
HDL
Tot Chol / HDL
Serum Glucose
Serum Insulin
Blood Pressure
Serum Triglyceride
Blood Pressure
Visceral Fat
LDL **
* Following Metabolic Adaptation period of 3 weeks to 2 months
** Not a primary marker, particularly requires analysis of other factors to interpret
62. Fundamental Truth
• To successfully gain excellent health and years of
extra life, I believe that you must actually
understand this science to a reasonable degree,
not just “follow the diet”. To achieve this
understanding will likely be the best thing you
ever do for yourself.
• Also, everyone has a different genetic makeup,
and this must be understood also – it’s not one
size fits all – know your phenotype!
(but the key drivers do have much commonality)
63. THE CRITICAL BIOCHEMISTRY OF
VITAMIN D
• Content in this draft slidepack for latest
science on 25 Hydroxy Vitamin D and related
mortality statistics will follow …..